The invention is concerned with novel hexafluoroisopropanol substituted ether derivatives of formula (I):
wherein R
1
to R
3
are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds bind to LXR alpha and LXR beta and can be used as medicaments.
这项发明涉及公式(I)的新型
六氟异丙醇取代醚衍
生物:
其中R1至R3如描述和索赔中定义,并且其生理上可接受的盐和酯。这些化合物与LXRα和LXRβ结合,可用作药物。